UNIGE document Scientific Article
previous document  unige:104567  next document
add to browser collection
Title

Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age

Authors
Trousson, Clémence
Biran, Valérie
Leroy, Emilie
Mohamed, Damir
Alberti, Corinne
Published in JAMA (Journal of the American Medical Association). 2017, vol. 317, no. 13, p. 1329-1337
Abstract Dexamethasone to prevent bronchopulmonary dysplasia in very preterm neonates was associated with adverse neurodevelopmental events. Early low-dose hydrocortisone treatment has been reported to improve survival without bronchopulmonary dysplasia but its safety with regard to neurodevelopment remains to be assessed.
Keywords Anti-Inflammatory Agents/adverse effects/therapeutic useBronchopulmonary Dysplasia/prevention & controlCerebral PalsyChild DevelopmentChild, PreschoolFemaleFollow-Up StudiesGestational AgeHumansHydrocortisone/adverse effects/therapeutic useInfantInfant, Extremely PrematureInfant, NewbornMaleNervous System Diseases
Identifiers
PMID: 28384828
Full text
Article (Published version) (334 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Prévention des complications néonatales d'origine périnatale (990)
Citation
(ISO format)
BAUD, Olivier et al. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age. In: JAMA (Journal of the American Medical Association), 2017, vol. 317, n° 13, p. 1329-1337. https://archive-ouverte.unige.ch/unige:104567

43 hits

0 download

Update

Deposited on : 2018-05-18

Export document
Format :
Citation style :